Cite
MLA Citation
C A Green et al.. “Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.” BMJ open, vol. 5, no. 10, 2015, p. . http://access.bl.uk/ark:/81055/vdc_100135558778.0x000006